GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » Cyclically Adjusted PB Ratio

Abbott India (BOM:500488) Cyclically Adjusted PB Ratio : 23.03 (As of Jun. 07, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abbott India Cyclically Adjusted PB Ratio?

As of today (2024-06-07), Abbott India's current share price is ₹26991.55. Abbott India's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₹1,172.03. Abbott India's Cyclically Adjusted PB Ratio for today is 23.03.

The historical rank and industry rank for Abbott India's Cyclically Adjusted PB Ratio or its related term are showing as below:

BOM:500488' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 18.27   Med: 21.77   Max: 28.75
Current: 22.08

During the past years, Abbott India's highest Cyclically Adjusted PB Ratio was 28.75. The lowest was 18.27. And the median was 21.77.

BOM:500488's Cyclically Adjusted PB Ratio is ranked worse than
97.96% of 737 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs BOM:500488: 22.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Abbott India's adjusted book value per share data for the three months ended in Mar. 2024 was ₹1,740.711. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹1,172.03 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Abbott India Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Abbott India's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India Cyclically Adjusted PB Ratio Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.85 19.79 19.55 21.55 22.99

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.55 - 21.00 - 22.99

Competitive Comparison of Abbott India's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Abbott India's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Abbott India's Cyclically Adjusted PB Ratio falls into.



Abbott India Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Abbott India's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=26991.55/1172.03
=23.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott India's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Abbott India's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1740.711/153.0345*153.0345
=1,740.711

Current CPI (Mar. 2024) = 153.0345.

Abbott India Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 94.103 0.000
201409 424.734 96.780 671.613
201412 0.000 96.780 0.000
201503 477.663 97.163 752.334
201506 0.000 99.841 0.000
201509 502.506 101.753 755.757
201512 0.000 102.901 0.000
201603 562.653 102.518 839.902
201606 0.000 105.961 0.000
201609 591.323 105.961 854.019
201612 0.000 105.196 0.000
201703 652.701 105.196 949.521
201706 0.000 107.109 0.000
201709 693.373 109.021 973.295
201712 0.000 109.404 0.000
201803 796.619 109.786 1,110.431
201806 0.000 111.317 0.000
201809 835.849 115.142 1,110.923
201812 0.000 115.142 0.000
201903 945.248 118.202 1,223.799
201906 0.000 120.880 0.000
201909 1,003.497 123.175 1,246.760
201912 0.000 126.235 0.000
202003 1,144.367 124.705 1,404.334
202006 0.000 127.000 0.000
202009 1,064.694 130.118 1,252.210
202012 0.000 130.889 0.000
202103 1,224.586 131.771 1,422.199
202106 0.000 134.084 0.000
202109 1,133.637 135.847 1,277.066
202112 0.000 138.161 0.000
202203 1,327.004 138.822 1,462.864
202206 0.000 142.347 0.000
202209 1,277.449 144.661 1,351.391
202212 0.000 145.763 0.000
202303 1,500.539 146.865 1,563.578
202306 0.000 150.280 0.000
202309 1,463.069 151.492 1,477.966
202312 0.000 152.924 0.000
202403 1,740.711 153.035 1,740.711

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abbott India  (BOM:500488) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Abbott India Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Abbott India's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (BOM:500488) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines